Users Stopping Anti-Obesity Jabs Regain Weight Far More Rapidly Than Dieters

Fresh analysis suggests that people who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.

Research printed in a leading health publication shows that while overweight individuals frequently drop about a fifth of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.

"Users purchasing these drugs need to be informed of the danger of fast rebound weight gain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.

Such speed of recovery implies a return to starting weight in about one and a half years.

Analyzing Approaches

The analysis, which examined dozens of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with conventional dieting.

Scientists note that individuals who shed pounds through lifestyle changes alone usually see a more gradual creep back—around 0.1 kg a month—after stopping.

Explaining the Fast Rebound

Experts suggest the mechanism of the jabs accounts for the heightened weight return.

The injections copy a natural hormone called GLP-1, which controls hunger.

"Artificially providing the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement means appetite is no longer kept in check, making overeating far more likely."

A Lifelong Condition?

The NHS advise the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.

Many experts say that, given the significant potential of weight regain, the treatment is often long-term.

This opinion is supported by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," comparing it to managing conditions like high blood pressure.

User Experiences

Individuals who have discontinued the medication describe a powerful resurgence of hunger.

"It was like a trigger flipping and I was suddenly ravenous," described an individual.

The struggle is worsened if patients have not developed permanent dietary or behavioural modifications during therapy.

Growing Adoption

Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Adoption is higher among females compared to men.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians caution that while the jabs are potent tools for shedding pounds, they are not a permanent fix and long-term success relies on combined lifestyle management.